Novel shift of Jak/Stat signalling characterizes the protective effect of aurintricarboxylic acid (ATA) from tumor necrosis factor-α toxicity in human B lymphocytes

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 1, 2004, Pages 5-14

  Marchisio, M ^a   Grimley, P M ^b   Di Baldassarre, A ^a   Santavenere, E ^a   Miscia, Sebastiano ^a,c  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Cell Signaling Unit   (Italy)

Author keywords

B lymphocites; Cytokines; Signal transduction

Indexed keywords

AURINTRICARBOXYLIC ACID; CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; JANUS KINASE 1; PROTEIN KINASE TYK2; SALICYLIC ACID DERIVATIVE; STAT PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5B PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; JAK1 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

AURINTRICARBOXYLIC ACID; B-LYMPHOCYTES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; HUMANS; JANUS KINASE 1; NF-KAPPA B; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 5444255232     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700102     Document Type: Article

References (32)

1. Fairbairn L.J., G.J. Cowling, B.M. Reipert and T.M. Dexter. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823.
2. Arch R.H. and C.B. Thompson. 1999. Lymphocyte survival the struggle against death. Annu. Rev. Cell. Dev. Biol. 15:113.
3. Akbar A.N., N.J. Borthwick, R.G. Wickremasinghe, P. Panayoitidis, D. Pilling, M. Bofill, S. Krajewski, J.C. Reed and M. Salmon. 1996. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax,bcl-xS) gene expression. Eur. J. Immunol. 26:294.
4. Lee S.F., H.M. Huang, J.R. Chao, S. Lin, H.F. Yang-Yen and J.J. Yen. 1999. Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis. Mol. Cell. Biol. 19:7399.
5. Acharya A. and S.M. Singh. 2001. Effect of TNF-alpha on the induction of apoptosis in murine macrophage role of interleukin-1 beta converting enzyme. Int. J. Immunopathol. Pharmacol. 14:5.
6. Bazzoni F. and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717.
7. Wallach D., E.E. Varfolomeev, N.L. Malinin, Y.V. Goltsev, A.V. Kovalenko and M.P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331.
8. Baxter G.T., R.C. Kuo, O.J. Jupp, P. Vandenabeele and D.J. MacEwan. 1999. Tumor necrosis factor alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J. Biol. Chem. 274:9539.
9. Belli F., A. Capra, A. Moroiti, S. Rossi and P. Rossi. 2000. Cytokines assay in peripheral blood and broncoalveolar lavage in the diagnosis and staging of pulmonary granulomatous deseases. Int. J. Immunopathol. Pharmacol. 13:61.
10. Ashkenazi A. and V.M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305.
11. Rath P.C. and B.B. Aggarwal. 1999. TNF-induced signaling in apoptosis. J. Clin. Immunol. 19:350.
12. Boldin M.P., T.M. Goncharov, Y.V. Goltsev and D. Wallach. 1996. Involvement of MACH, a novel MORT1/ FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85:803.
13. Muzio M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, M. Mann, P.H. Krammer, M.E. Peter and V.M. Dixit. 1996. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 85:817.
14. Thornberry N.A. and Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312.
15. Slee E.A., M.T. Harte, R.M. Kluck, B.B. Wolf, C.A. Casiano, D.D. Newmeyer, H.G. Wang, J.C. Reed, D.W. Nicholson, E.S. Alnemri, D.R. Green and S.J. Martin. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases -2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell. Biol. 144:281.
16. Saleh A., S.M. Srinivasula, S. Acharya, R. Fishel and E.S. Alnemri. 1999. Cytochrome c and dATPmediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. 274:17941.
17. Trubiani O., S. Guarnieri, R. Paganelli and R. Di Primio. 2002. Involvement of Caspace-3 in the cleavage of terminal transferase. Int. J. Immunopathol. Pharmacol. 15:201.
18. Arch R.H., R.W. Gedrich and C.B. Thompson. 2000. Translocation of TRAF proteins regulates apoptotic threshold of cells. Biochem. Biophys. Res. Commun. 272:936.
19. Wajant H., M. Grell and P. Scheurich. 1999. TNF receptor associated factors in cytokine signaling. Cytokine Growth Factor Rev. 10:15.
20. Miscia S., M. Marchisio, A. Grilli, V. Di Valerio, L. Centurione, G. Sabatino, F. Garaci, G. Zauli, E. Bovini and A. Di Baldassarre. 2002. Tumor Necrosis Factor a (TNF-α) activates JAK1/STAT3-STAT5b signalling through TNFR-1 in human B cells. Cell Growth Diff. 13:13.
21. Chen, C.W., Y. Chao, Y.H. Chan, M.J. Hsux and W.W. Lin. 2002. Inhibition of cytokine induced JAK-STAT signalling pathways by endonuclease inhibitor aurintricarboxylic acid. British J. Pharmacol. 137:1011.
22. Rui H., J. Xu, S. Mehta, H. Fang, J. Williams, F. Dong and P.M. Grimley. 1998. Activation of the JAK2-STAT5 signaling pathway in Nβ2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid. J. Biol. Chem. 273:28.
23. Tsi C.J., Y. Chao, C.W. Chen and W.W. Lin. 2002. Aurintricarboxylic acid protects cell death from LPS in macrophages: decrease iNOS induction via IKK, ERK, and p38 MAPK inhibition. Mol. Pharmacol. 62:90.
24. Miscia S., A. Di Baldassarre and A. Cataldi. 1997. Shift of DNA polymerase a distribution and activity in apoptotic human leukemia cells. Biochem. Biophys. Res. Comm. 234:303.
25. Beutler B.A. 1999. The role of tumor necrosis factor in health and disease. J. Rheumatol. 26:16.
26. Zingarelli B., F. Squadrito, D. Altavilia, G. Calapai, M. Di Rosa and A.P. Caputi. 1994. Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am. J. Physiol. 266:H1512.
27. Squadrito F., D. Altavilla, G. Squadrito, M. Ferlito, G.M. Campo, M. Arlotta, S. Grimaldi, C. Quartarone, A. Saitta and A.P. Caputi. 1999. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock. Br. J. Pharmacol. 127:498.
28. Young P.R. 1998. Pharmacological modulation of cytokine action and production through signaling pathways. Cytokine Growth Factor Rev. 9:239.
29. +2 homeostasis during hemorrhagic shock in the rat. J. Mol. Med. 77:8.
30. Walker D.H. 1997. Small-molecule inhibitors of cyclin-dependent kinases: molecular tools and potential therapeutics. In Cyclin Dependent Kinase (CDK) inhibitors. P.K. Vogt and S.I. Reed, ed. Springer Heidelberg, p. 149.
31. Leonard W.J. and J.J. O'Shea. 1998. JAKs and STATs: biological implication. Ann. Rew. Immunol. 16:293.
32. Mowen K. and M. David. 2000. Regulation of Stat1 nuclear export by Jak1. Mol. Cell. Biol. 20:7273.